JP2020510700A5 - - Google Patents

Info

Publication number
JP2020510700A5
JP2020510700A5 JP2019571099A JP2019571099A JP2020510700A5 JP 2020510700 A5 JP2020510700 A5 JP 2020510700A5 JP 2019571099 A JP2019571099 A JP 2019571099A JP 2019571099 A JP2019571099 A JP 2019571099A JP 2020510700 A5 JP2020510700 A5 JP 2020510700A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
eil
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019571099A
Other languages
English (en)
Japanese (ja)
Other versions
JP7365240B2 (ja
JP2020510700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/055644 external-priority patent/WO2018162577A1/en
Publication of JP2020510700A publication Critical patent/JP2020510700A/ja
Publication of JP2020510700A5 publication Critical patent/JP2020510700A5/ja
Application granted granted Critical
Publication of JP7365240B2 publication Critical patent/JP7365240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019571099A 2017-03-07 2018-03-07 馬の掻痒の治療 Active JP7365240B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17159644.8 2017-03-07
EP17159644 2017-03-07
PCT/EP2018/055644 WO2018162577A1 (en) 2017-03-07 2018-03-07 Treatment of pruritus in horses

Publications (3)

Publication Number Publication Date
JP2020510700A JP2020510700A (ja) 2020-04-09
JP2020510700A5 true JP2020510700A5 (enExample) 2022-09-20
JP7365240B2 JP7365240B2 (ja) 2023-10-19

Family

ID=58397991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019571099A Active JP7365240B2 (ja) 2017-03-07 2018-03-07 馬の掻痒の治療

Country Status (7)

Country Link
US (3) US11207390B2 (enExample)
EP (1) EP3592378A1 (enExample)
JP (1) JP7365240B2 (enExample)
CN (1) CN110381990A (enExample)
AU (1) AU2018231413B2 (enExample)
CA (1) CA3054389A1 (enExample)
WO (1) WO2018162577A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3093709C (en) 2018-03-16 2024-03-26 Zoetis Services Llc Peptide vaccines against interleukin-31
JP7449234B2 (ja) 2018-03-16 2024-03-13 ゾエティス・サービシーズ・エルエルシー 獣医学使用のためのインターロイキン３１モノクローナル抗体
AU2019278596A1 (en) * 2018-05-28 2020-12-24 Evax Ag Treatment of urticaria
WO2021083766A1 (en) 2019-10-29 2021-05-06 Evax Ag Treatment of pruritus in horses
CA3211221A1 (en) * 2021-02-22 2022-08-25 Zoetis Services Llc Horse il-31 induced pruritus model
CN119136838A (zh) 2022-02-28 2024-12-13 特瑞德姆生物科技有限责任两合公司 由至少一种β-葡聚糖或甘露聚糖组成或包含至少一种β-葡聚糖或甘露聚糖的偶联物
AR133291A1 (es) * 2023-07-19 2025-09-17 Inst Pasteur De Montevideo Inmunización activa para el tratamiento de la dermatitis atópica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
DE60230656D1 (de) * 2001-11-07 2009-02-12 Cytos Biotechnology Ag Antigenraster welche il-5, il-13 oder eotaxin präshilen erkrankungen
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
US10556003B2 (en) * 2015-09-08 2020-02-11 Universität Zürich Treatment of insect bite hypersensitivity
US10093731B2 (en) * 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use

Similar Documents

Publication Publication Date Title
JP7455785B2 (ja) 虫刺され過敏症の治療
US20250281582A1 (en) Treatment of pruritus in horses
KR102469478B1 (ko) 개 아토피성 피부염의 치료
JP2025118600A (ja) じんましんの治療
CN119789863A (zh) 经修饰的cmv病毒样颗粒
AU2009221114A1 (en) Use of interleukin-1 conjugates in the treatment of diabetes
WO2021083766A1 (en) Treatment of pruritus in horses
HK40044288A (en) Treatment of urticaria
HK1252263B (en) Treatment of insect bite hypersensitivity